In this study, a TNF-α-targeted US contrast agent, MBTNF-α, was developed, and ex vivo intracolic USMI experiments using MBTNF-α were successfully conducted to accurately quantify mTNF-α expression in colons excised from a murine model of colitis. This evidence concerns the gene TNF and colitis.